Nan Fung Group has established Pivotal Bioventure Partners China to build a concentrated portfolio of high-quality life science assets and nurture them from inception to exit
Incubation has become the prevailing trend among early-stage China healthcare investors. Lilly Asia Ventures pursues an incubation model whereby the GP launches new start-ups internally or backs entrepreneurs...
The Asian Development Bank (ADB) has agreed to invest $25 million in Exacta Asia Investment II (Exacta II), a Southeast Asia-focused vehicle launched last year by Japan’s Mizuho Bank.
Bcause, a US-based cryptocurrency services company backed by SBI Holdings has received a commitment of undisclosed size from China Health Checkmate (CHC) to support an Asian expansion.
Wukongbao, a Beijing-based online insurance broker, has raised millions of US dollars in a Series B round led by Chinese classifieds platform 58.com, with participation from Guohua Life Insurance.